Registry of Lobbyists
Version 2 of 2 (2006-03-08 to 2006-05-17) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.
| Corporation: |
ID BIOMEDICAL CORPORATION
525 Cartier West Laval, QC H7V 3S8 Canada |
| Telephone number: | 450-978-6301 |
| Fax number: | 450-978-7956 |
| Responsible officer name and position during the period of this registration: | Anthony Holler, CEO |
| Description of activities: | On December 8th, 2005, GlaxoSmithKline purchased all the issued and outstanding shares of ID Biomedical Corporation. The Corporation has nonetheless survived the closing of the above noted transaction and now carries on business as IB Biomedical Corporation cob as GlaxoSmithKline Biologicals North America. The Corporation is an integrated biotechnology company dedicated to the development of innovative vaccine products. It operates in research, development, manufacturing, sales and marketing from its facilities in Canada and in the United States. |
| Parent: | The corporation is not a subsidiary of any other parent corporations. |
| Coalition | The corporation is not a member of a coalition. |
| Subsidiary: | The corporation does not have any subsidiaries that could be affected by the outcome of the undertaking. |
| Other direct interests | The corporation's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking. |
| Was the corporation funded in whole or in part by any domestic or foreign government institution in the last completed financial year? | No |
| Name: | MICHEL BAIJOT |
| Position title: | VP BUSINESS DEVELOPMENT |
| Public offices held: | No |
| Name: | RABIH KYRIAKOS |
| Position title: | ASSOCIATE DIRECTOR, SALES AND MARKETING |
| Public offices held: | No |
| Name: | LAZLO PALKONYAY |
| Position title: | VICE PRESIDENT GOVERNMENTAL AFFAIRS |
| Public offices held: | Yes |
| Federal departments or organizations which have been or will be communicated with during the course of the undertaking: | Health Canada (HC), Industry Canada, Public Works and Government Services Canada, Treasury Board Of Canada Secretariat (TBS) | ||||
|
Communication techniques that have been used or are expected to be used in the course of the undertaking:
|
Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format | ||||
| Subject Matter: Areas of Concern: | Government Procurement, Health, Industry, Internal Trade, Science and Technology, Taxation and Finance | ||||
| Subject Matter: Retrospective: | The company deals on a regular basis with Public Office Holders of the Canadian Government working for the following Governmental Deparments: Industry Canada, Health Canada, Public Works Government Canada Services, BGTD.The company is party to Canadian Government Funding Agreements under the Technology Partnership Canada. The company is also supplier to the Canadian Government and the Provinces of two vaccines, including 75% of Canada's need for an Influenza Vaccine. | ||||
| Subject Matter: Prospective: | As the Company is the principal supplier of influenza vaccines to the Government of Canada and considering the potential risk of a worldwide influenza pandemic, the Company is in frequent contact with Canadian Government Public Office holders in this regard. | ||||
Details Regarding the Identified Subject Matter
|
|||||